5-(2-(Methanesulfonyloxy)ethoxy)-2-methylquinazoline → 8-{1-[2-(2-Methylquinazolin-5-yloxy)ethyl]piperidin-4-ylmethyl}-4H-benzo[1,4]oxazin-3-one
반응식
[CH3:19][S:20]([O:21][CH2:24][CH2:25][O:26][c:27]1[c:28]2[cH:29][n:30][c:31]([CH3:37])[n:32][c:33]2[cH:34][cH:35][cH:36]1)(=[O:22])=[O:23].[NH:1]1[CH2:2][CH2:3][CH:4]([CH2:7][c:8]2[cH:9][cH:10][cH:11][c:12]3[c:17]2[O:16][CH2:15][C:14](=[O:18])[NH:13]3)[CH2:5][CH2:6]1>>[N:1]1([CH2:24][CH2:25][O:26][c:27]2[c:28]3[cH:29][n:30][c:31]([CH3:37])[n:32][c:33]3[cH:34][cH:35][cH:36]2)[CH2:2][CH2:3][CH:4]([CH2:7][c:8]2[cH:9][cH:10][cH:11][c:12]3[c:17]2[O:16][CH2:15][C:14](=[O:18])[NH:13]3)[CH2:5][CH2:6]1참가 물질
3
출처 및 근거
- ORD 기록
- ord-467714fb40e24cdf8f26abcaa67e0cc6
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (5/10)
반응 노트
불러오는 중…